PROGNOSTIC IMPACT OF AGE WITH SHORT-TERM VS. 12 MONTHS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: A SUB-ANALYSIS OF THE REDUCE TRIAL

被引：0

作者：

Verdoia, Monica ^{[1
]}

Suryapranata, Harry ^{[1
]}

Damen, Sander ^{[1
]}

Camaro, Cyril ^{[1
]}

Rasoul, Saman ^{[1
]}

Liew, Houngbang ^{[1
]}

Polad, Jawed ^{[1
]}

Ahmad, Abdul Muhaimin ^{[1
]}

Zambahari, Robaayah ^{[1
]}

Lalmand, Jacques ^{[1
]}

van der Schaaf, R. J. ^{[1
]}

Koh, Tian Hai ^{[1
]}

Timmermans, Frank ^{[1
]}

Dilling-Boer, D. ^{[1
]}

Veenstra, Leo ^{[1
]}

van't Hof, Arnoud ^{[1
]}

Lee, Swl ^{[1
]}

Roolvink, Vincent ^{[1
]}

Ligtenberg, Erik ^{[1
]}

Postma, Sonja ^{[1
]}

Kolkman, Evelien ^{[1
]}

Brouwer, Marc ^{[1
]}

Dudek, Dariusz ^{[1
]}

Kedhi, Elvin ^{[1
]}

De Luca, Giuseppe ^{[1
]}

机构：

[1] Univ Piemonte Orientale, Novara, Italy

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1153-041

引用

页码：1229 / 1229

页数：1

共 50 条

[1] Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: a 1-year analysis of the REDUCE trial
Verdoia, M.
Suryapranata, H.
Damen, S.
Camaro, C.
Benit, E.
Barbieri, L.
Rasoul, S.
Hof, A. W. Van T.
Roolvink, V.
Ligtenberg, E.
Postma, S.
Kolkman, J. J. E.
Brouwer, M. A.
Kedhi, E.
De Luca, G.
EUROPEAN HEART JOURNAL, 2019, 40 : 3409 - 3409
[2] Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial
Verdoia, M.
Suryapranata, H.
Damen, S.
Camaro, C.
Benit, E.
Barbieri, L.
Rasoul, S.
Liew, H. B.
Polad, J.
Ahmad, W. A. W.
Zambahari, R.
Lalmand, J.
van der Schaaf, R. J.
Koh, T. H.
Timmermans, P., Sr.
Dilling-Boer, D.
Veenstra, L. F.
Van't Hof, A. W. J.
Lee, S. W. L.
Roolvink, V.
Ligtenberg, E.
Postma, S.
Kolkman, E. J. J.
Brouwer, M. A.
Kedhi, E.
De Luca, G.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 797 - 807
[3] Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial
M. Verdoia
H. Suryapranata
S. Damen
C. Camaro
E. Benit
L. Barbieri
S. Rasoul
H. B. Liew
J. Polad
W. A. W. Ahmad
R. Zambahari
J. Lalmand
R. J. van der Schaaf
T. H. Koh
P Timmermans
D. Dilling-Boer
L. F. Veenstra
A. W. J. van’t Hof
S. W. L. Lee
V. Roolvink
E. Ligtenberg
S. Postma
E. J. J. Kolkman
M. A. Brouwer
E. Kedhi
G. De Luca
Journal of Thrombosis and Thrombolysis, 2021, 52 : 797 - 807
[4] Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial
Kedhi, Elvin
Verdoia, Monica
Suryapranata, Harry
Damen, Sander
Camaro, Cyril
Benit, Edouard
Barbieri, Lucia
Rasoul, Saman
Liew, Houng B.
Polad, Jawed
Ahmad, Wan A. W.
Zambahari, Robaayah
Lalmand, Jacques
van der Schaaf, Rene J.
Koh, Tian H.
Timmermans, Philippe
Dilling-Boer, Dagmara
Veenstra, Leo F.
van' t Hof, Arnoud W. J.
Lee, Stephen W. L.
Roolvink, Vincent
Ligtenberg, Erik
Postma, Sonja
Kolkman, Evelien J. J.
Brouwer, Marc A.
Dudek, Dariusz
De Luca, Giuseppe
ATHEROSCLEROSIS, 2021, 321 : 39 - 44
[5] Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial
Camaro, Cyril
Damen, Sander A. J.
Brouwer, Marc A.
Kedhi, Elvin
Lee, Stephan W.
Verdoia, Monica
Barbieri, Lucia
Rognoni, Andrea
vant Hof, Arnoud W. J.
Ligtenberg, Erik
de Boer, Menko-Jan
Suryapranata, Harry
De Luca, Giuseppe
AMERICAN HEART JOURNAL, 2016, 178 : 37 - 44
[6] Dual antiplatelet therapy in patients with an acute coronary syndrome: up to 12 months and beyond
Pareek, Manan
Bhatt, Deepak L.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2018, 20 (0B) : B21 - B28
[7] SINGLE VS. DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME - A META-ANALYSIS
Ullah, Waqas
Uddin, Mohammed Faisal
Sandhyavenu, Harigopal
Sattar, Yasar
Zghouzi, Mohamed
Suleiman, Abdul-Rahman M.
Pasha, Ahmed
Zahid, Salman
Alraies, M. Chadi
Sabouret, Pierre
Fischman, David
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 18 - 18
[8] Three Months vs 12-Months Dual Antiplatelet Therapy Duration in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Selvaraj, Vijairam
Moustafa, Abdelmoniem
Bavishi, Chirag
CIRCULATION, 2021, 144
[9] Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)
De Luca, Giuseppe
Damen, Sander A.
Camaro, Cyril
Benit, Edouard
Verdoia, Monica
Rasoul, Saman
Liew, Houng Bang
Polad, Jawed
Ahmad, Wan A.
Zambahari, Robaayah
Postma, Sonja
Kedhi, Elvin
Suryapranata, Harry
EUROINTERVENTION, 2019, 15 (11) : E990 - +
[10] Short-Term and DeEscalation Dual Antiplatelet Therapy for Patients With Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis
Kuno, Toshiki
Watanabe, Atsuyuki
Shoji, Satoshi
Fujisaki, Tomohiro
Takagi, Hisato
Deharo, Pierre
Cuisset, Thomas
Kohsaka, Shun
Bhatt, Deepak L.
CIRCULATION, 2022, 146

← 1 2 3 4 5 →